Orexigen Therapeutics, Inc. (OREX) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts OREX Hot Sheet
Price: $0.22 --0%
Financial Fact:
Research and development: 5.25M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 5.25M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Orexigen Therapeutics, Inc. (NASDAQ: OREX) reported Q2 EPS of ($0.16), $0.04 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $857 thousand versus the consensus estimate of $740 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
